Airfinity Ltd
Sarah Harper has extensive experience in media and communications. Sarah is currently serving as the Head of Media and Communications at Airfinity Ltd. Prior to this, they worked at ITN Productions as an Editor of the commercial news team, managing a team of journalists and producing news content for various digital publishers and broadcasters. Sarah also worked as a Digital Editor at ITN Productions and as a News Producer at ITV News. Additionally, Sarah has experience as a Digital News Producer at ITN Productions, a Producer/Newsreader at Sky News Radio/Independent Radio News Ltd, and an Interviews and Output Producer at Sky News. Sarah began their career as a Broadcast Assistant at GMTV (Northern Ireland) and UTV Television.
Sarah Harper attended the HunterHouse College Prep and later Hunterhouse College, but no specific dates for these educational experiences were provided. In 2004, they enrolled at Ulster University, where they pursued a Bachelor of Science Honors degree in Communication, Advertising, and Marketing. Sarah completed their undergraduate studies in 2008. Following this, in 2009, Sarah attended the University of the Arts London, where they obtained a Postgraduate Diploma in Broadcast Journalism, completing their studies in 2010.
This person is not in any teams
Airfinity Ltd
Airfinity is a pioneer in predictive health analytics that decision makers can trust, understand and act on to preempt future health risks.Specialising in infectious diseases, Airfinity has a comprehensive suite of world-leading market intelligence solutions, turning disconnected data points into real time predictive indicators. The platform alsocovers advanced therapies (e.g. RNA, Gene and Cell Therapy) and cardio-metabolic.Disease-centric solutions combine proprietary surveillance tools and forecast models with expert analysis to produce actionable insights on pipeline developments, standard of care, regulatory trends and demand and supply.Airfinity is a global company with headquarters in London and Boston, relied upon across the full ecosystem in life sciences, including pharma companies, government agencies, corporates, investors, NGOs, and international organisations.